HMGB1 has been shown to be a potent mediator of late septic shock that results from endotoxin stimulation of macrophages [29],[58] and there are indications that it may be a valuable therapeutic target in the treatment of sepsis [59]. The gene discussed is HMGB1; the disease is Sepsis.